Deletion of interleukin-6 in mice with the dominant negative form of transforming growth factor beta receptor II improves colitis but exacerbates autoimmune cholangitis.

Zhang W; Tsuda M; Yang GX; T suneyama K; et al.

Deletion of interleukin-6 in mice with the dominant negative form of transforming growth factor beta receptor II improves colitis but exacerbates autoimmune cholangitis.

Zhang W, Tsuda M, Yang GX, T suneyama K, et al.

Research output: Contribution to journal › Article › peer-review

Original language	Japanese
Pages (from-to)	215-222
Journal	Hepatology
Volume	52(1)
State	Published - 2010
Externally published	Yes

Cite this

@article{76549b81a0c24f308a3d6bbc7557ba21,

title = "Deletion of interleukin-6 in mice with the dominant negative form of transforming growth factor beta receptor II improves colitis but exacerbates autoimmune cholangitis.",

author = "Zhang W and Tsuda M and Yang GX and {suneyama K}, T and et al.",

year = "2010",

language = "日本",

volume = "52(1)",

pages = "215--222",

journal = "Hepatology",

issn = "0270-9139",

publisher = "Lippincott Williams and Wilkins",

}

TY - JOUR

T1 - Deletion of interleukin-6 in mice with the dominant negative form of transforming growth factor beta receptor II improves colitis but exacerbates autoimmune cholangitis.

AU - W, Zhang

AU - M, Tsuda

AU - GX, Yang

AU - suneyama K, T

AU - al., et

PY - 2010

Y1 - 2010

M3 - 学術論文

SN - 0270-9139

VL - 52(1)

SP - 215

EP - 222

JO - Hepatology

JF - Hepatology

ER -